Nanomedicine and neurodegenerative disorders: so close yet so far.
This editorial provides an overview of the main advantages of the use of nanomedicine-based approach for innovation in the treatment of neurodegenerative diseases. Besides these aspects, a critical analysis on the main causes that slow the application of nanomedicine to brain disorders is given along with the identification of possible solutions and possible interventions. Better communication between the main players of research in this field and a detailed understanding of the most critical issues to be addressed should help in defining future directions towards the improvement and, finally, the clinical application of nanomedicine to neurodegenerative diseases.
University of Modena and Reggio Emilia, Department of Life Sciences, Nanomedicine Group , 41124, Modena , Italy +39 059 2055128 ; +39 059 2055131 ; gtosi@unimore.it.
Giovanni
G
Tosi
Maria Angela
MA
Vandelli
Flavio
F
Forni
Barbara
B
Ruozi
D000818:Animals; D006801:Humans; D050997:Nanomedicine / Q000639:trends*; D019636:Neurodegenerative Diseases / Q000188:drug therapy*
brain; drug delivery and targeting; nanomedicine; neurodegenerative disorders